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Abstract
Background: Several studies have suggested that adverse neurodevelopment could be induced by systemic
inflammation in preterm infants. We aimed to investigate whether preterm infants with systemic inflammation
would have impaired neurodevelopment and which biomarkers and neurophysiologic studies during inflammation
are associated with poor neurodevelopment.
Methods: This prospective cohort study enrolled infants born before 30 weeks of gestation or with birth weight
< 1250 g. Infants were grouped according to the presence of systemic inflammation: Control (no inflammation,
n = 49), I (systemic inflammation, n = 45). Blood and cerebrospinal fluid samples for markers of brain injury and
inflammation were collected and amplitude-integrated electroencephalography (aEEG) was performed within 4 h of
septic workup. We evaluated aEEG at 35 weeks postmenstrual age (PMA), head circumference at 36 weeks PMA, and
brain MRI at discharge. The Bayley Scales of Infant and Toddler Development III (Bayley-III) was performed at a
corrected age (CA) of 18 months.
Results: The I group had more white matter injuries (2 vs. 26.7%, Control vs. I, respectively) at the time of
discharge, lower brain functional maturation (9.5 vs. 8), and smaller head size (z-score − 1.45 vs. -2.12) at near-term
age and poorer neurodevelopment at a CA of 18 months than the control (p < 0.05). Among the I group, the
proportion of immature neutrophils (I/T ratios) and IL-1 beta levels in the CSF were associated with aEEG measures
at the day of symptom onset (D0). Seizure spike on aEEG at D0 was significantly correlated with motor and social-
emotional domains of Bayley-III (p < 0.05). The I/T ratio and CRP and TNF-α levels of blood at D0, white matter
injury on MRI at discharge, head circumference and seizure spikes on aEEG at near-term age were associated with
Bayley-III scores at a CA of 18 months.
Conclusions: Systemic inflammation induced by clinical infection and NEC are associated with
neurodevelopmental impairment in preterm infants. The seizure spike on aEEG, elevated I/T ratio, CRP, and plasma
TNF-alpha during inflammatory episodes are associated with poor neurodevelopment.
Keywords: Premature, White matter injury, Sepsis, Necrotizing enterocolitis, Inflammation, Amplitude integrated
encephalography, Cytokine
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Background
As the survival rate of preterm infants has increased, the
management of long-term complications, especially neu-
rodevelopmental impairment, becomes important [1].
The most common brain injury in premature infants is
periventricular leukomalacia [2], and its pathogenesis in-
volves the effect of hypoxia, ischemia, and inflammation
of the progenitor oligodendrocyte cells present during
weeks 23–32 of gestation [3].
Preterm infants are at a high risk for infection, and
infection-induced inflammation was found to contribute
to adverse neurodevelopment in several clinical and ani-
mal studies [4–8]. The mechanisms of systemic
inflammation-induced neuronal injury have not been
fully elucidated, but systemic inflammation is known to
disrupt the blood-brain barrier and incite a local inflam-
matory response in the brain [7, 9]. The magnitude of
systemic inflammation is possibly reflected in the level
of blood inflammatory markers and these markers could
indicate the high-risk preterm infants for brain injury
and poor neurodevelopment at a later stage. A valid
diagnostic biomarker needs to be designed for evaluation
in a clinical setting of systemic inflammatory state [10–
12].. Furthermore, current neonatal intensive care in-
creasingly utilizes non-invasive brain monitors, such as
amplitude-integrated electroencephalography (aEEG), to
detect acute brain injury, and a previous study showed
that aEEG was associated with inflammatory markers
and neurodevelopment [13]. However, there have been
few studies on the association between adverse neurode-
velopment and inflammatory markers or aEEG findings
during systemic inflammatory episodes that preterm in-
fants experience during neonatal intensive care unit
(NICU) admission.
The objective of this study is two-fold: first, to investi-
gate whether preterm infants who experienced systemic
inflammation induced by clinical infection and NEC are
more susceptible to impaired short-term neurological
and CA of 18months neurodevelopmental outcomes in
our study population, and second, to examine the associ-
ation of laboratory markers including inflammatory cy-
tokines and brain injury markers and aEEG at the time
of systemic inflammation in the NICU and neurodeve-
lopmental outcomes. We hypothesized that inflamma-
tion increases cytokine levels and causes brain injury,




This was a prospective cohort study. We recruited in-
fants born before 30 weeks of gestation, or whose birth
weights was less than 1250 g, and were admitted to the
NICU of the Seoul National University Children’s
Hospital from December 2013 to June 2017. We ex-
cluded infants with congenital anomalies and grade IV
intraventricular hemorrhage (IVH).
The subjects were grouped according to the pres-
ence of systemic inflammation. During the NICU stay,
systemic infection was clinically suspected if there
were at least two newly developed signs of fever,
apnea, difficulty in breathing, tachycardia or bradycar-
dia, hypotension, irritability, lethargy, and feeding in-
tolerance. For such infants, blood tests, including
blood culture, complete blood count (CBC), and C-
reactive protein (CRP), were performed subsequently
for sepsis evaluation. If at least one of the following
abnormal laboratory findings was revealed: (1) eleva-
tion of CRP > 1.0 mg/dL, (2) abnormal CBC of
elevated proportion of immature neutrophils (I/T ra-
tio ≥ 0.2), or platelets ≤100 × 109/L, and parenteral an-
tibiotics were administered for more than 5 days, they
were designated to the systemic inflammation group
(I). I group would include subjects who revealed posi-
tive blood cultures or were diagnosed with stage II or
higher necrotizing enterocolitis (NEC) when they ful-
filled aforementioned criteria. If infants did not de-
velop any septic episodes during the NICU stay or
show negative laboratory results after the sepsis
workup, they were designated to the control group.
In the I group, CBC with differential counts and CRP
level were evaluated on day zero (the day of symptom
onset), two, and six of the inflammatory episodes along
with an aEEG. We performed aEEG within 4 h of septic
workup. In addition, plasma and cerebrospinal fluid
(CSF) samples were obtained for cytokine and brain in-
jury marker analysis. The CSF tapping was performed
for patients suspected of having sepsis or central nervous
system infection. For the entire cohort, an aEEG was
performed at 35 weeks of postmenstrual age (PMA), a
brain MRI was performed before discharge from the
NICU, and follow-up information was collected at a cor-
rected age (CA) of 18 months.
To determine whether systemic inflammation is as-
sociated with abnormal neurologic or neurodevelop-
mental outcomes, we compared HC, aEEG, brain
MRI, and Bayley scores between the I and control
groups. In addition, to identify predictors of neuro-
logic and neurodevelopmental impairment among in-
fants who experienced systemic inflammation, we
analyzed the correlation between biomarkers and neu-
rodevelopmental outcomes. This study followed the
guidelines set by Declaration of Helsinki and received
ethical approval for human subject by the Institu-
tional Review Board of Seoul National University
Hospital, and written informed consent was obtained
from the parents following a detailed description of
the purpose of the study (IRB No. 1301–058-458).
Lee et al. BMC Pediatrics          (2021) 21:114 Page 2 of 11
aEEG
For infants in the I group, aEEG recordings were per-
formed on day 0 (the day of onset of symptoms), 2, and
6 of the inflammatory episodes and at 35 weeks PMA.
The infants in the control group were only assessed at
35 weeks PMA. A portable electroencephalogram moni-
tor, Olympic Cerebral Function Monitor (Olympic Med-
ical, Seattle, USA), was used. Continuous impedance was
measured, and the electrodes were deemed to be well
applied when the impedance was less than 10 kΩ. Con-
tinuous recording was performed over 3 h [14–16]. The
aEEG scoring system was used to evaluate a maturation
score. Four components of the aEEG, including continu-
ity, cycling, amplitude of the lower border, and band-
width span, were evaluated and the summed score
ranged from 0 to 13 [14]. In addition, we classified the
aEEG background activity as normal amplitude, the
upper margin of band of aEEG activity > 10 μV and the
lower margin > 5 μV; moderately abnormal amplitude,
the upper margin of band of aEEG activity > 10 μV and
the lower margin ≤5 μV; and suppressed amplitude, the
upper margin of the band of aEEG activity < 10 μV and
lower margin < 5 μV [17]. We monitored the seizure
spike at a rapid rise in both the lower and upper margins
of the trace, which usually exhibits a ‘saw tooth’ pattern.
We also evaluated the simultaneous raw EEG data [18].
Cytokine and brain injury marker analysis (plasma and
CSF)
Plasma samples were collected on the day of symptom
onset (day 0). CSF samples were obtained when CSF tap-
ping was performed for patients suspected of having sep-
sis or CNS infection. The analyses of IL-1 beta, IL-6, IL-
8, Myelin Basic Protein (MBP), Tumor Necrosis Factor-
alpha (TNF-alpha), S100B, Glial fibrillary acidic protein,
and Enolase 2 were performed [19]. The enzyme-linked
immunosorbent assay kit (Cloud-Clone Corp, Houston,
Texas, USA) and Quantikine® (R&D systems, Minneap-
olis, Minnesota, USA) were used for the quantitative
determination of cytokines and brain injury markers.
Brain MRI
Brain MRI, including T2 and T1-weighted sequences,
was performed at discharge. Experienced pediatric radi-
ologists assessed the degree of white matter injury
(WMI) by scoring five categories on MRI, including the
nature and extent of white matter signal abnormality,
periventricular white matter volume loss, cystic abnor-
malities, ventricular dilatation, and thinning of the cor-
pus callosum [20]. These five scores were summed and
WMI on MRI was categorized as none (total score 5–6),
mild (total score 7–9), and moderate to severe (total
score 10–15). The radiologists were blinded to the
clinical status of the patients.
Follow-up outcomes at a CA of 18months
Body measurement data, including weight, length, and
head circumference, were collected at a CA of 18
months. The diagnosis of cerebral palsy were collected.
The diagnosis of cerebral palsy was made at the discre-
tion of rehabilitation specialists [21]. The patients were
assessed using the Bayley Scales of Infant and Toddler
Development - the 3rd edition (Bayley-III). The Bayley-
III generates composite scores for five domains includ-
ing cognitive, language, motor, social-emotional, and
adaptive behavior [22].
Statistical analysis
Statistical analyses were performed using the SPSS Sta-
tistics 20.0 software (SPSS Inc., Chicago, IL, USA). The
chi-squared test was used to compare categorical data
between the groups, while the Mann-Whitney U tests
were used to compare quantitative data between groups.
ANCOVA was used to analyze differences between
groups in head circumference, aEEG maturation scores,
WMI on MRI, Bayley scores, and incidence of cerebral
palsy, while controlling for gestational age (GA), 1- and
5-min Apgar scores, respiratory distress syndrome
(RDS), bronchopulmonary dysplasia (BPD), patent
ductus arteriosus (PDA) operation, retinopathy of pre-
maturity (ROP) (≥stage III), and IVH (≥Grade III). Pear-
son’s partial correlation analysis (adjusted for PMA of
the inflammatory event and GA) was used to evaluate
the relationship between the biomarkers and neuro-
logical outcomes including aEEG, brain MRI, and HC in
the I group. Correlation analysis (adjusted for PMA of
the inflammatory event and GA) was performed to as-
sess the relationship between biomarkers and the results
of neurological evaluation, including aEEG, brain MRI,
and HC and Bayley scores at a CA of 18 months. P-
values < 0.05, two-tailed, were considered statistically
significant.
Results
Study population and data collection
Of the 100 preterm infants enrolled in the study, five in-
fants who died before 35 weeks of PMA and one infant
with IVH grade IV were excluded. There were 49 infants
in the control and 45 infants in the I group including 10
infants for culture-proven sepsis, one infant for stage II
or higher NEC and one infant for both culture-proven
sepsis and stage II or higher NEC. No infants were diag-
nosed with meningitis. The median PMA at the inflam-
matory episode were 29+ 6 (24+ 0–34+ 6) weeks, and the
median postnatal days of inflammatory episodes with
septic work up were 17 (0, 85) days. Nineteen infants
had early onset (postnatal days < 7 days) events (Fig. 1).
aEEG at 35 weeks PMA was performed in 43 (88%) in-
fants in the control group and 38 (84%) infants in the I
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group. aEEG during an inflammatory episode was per-
formed in 26 (58%) infants in the I group. CBC and CRP
levels were measured in all infants in the I group. CSF
examination was performed in 14 (31%) infants in the I
group. Plasma biomarker analyses were performed in 23
(51%) infants on samples collected at symptom onset (day
0), if available. Brain MRI was performed on 37 (75%) and
40 (89%) infants in the control and I groups, respectively.
The median age at which brain MRI performed was 37+ 2
(33+ 0, 62+ 3) weeks. In one case, infarction was found on
routine brain sonography and MRI was performed at 33
weeks PMA. Bayley test was performed on 43 (88%) infants
in the control group and 42 (93%) infants in the I group.
Perinatal characteristics and neonatal morbidities
The GA (29+ 2 vs. 26+ 6; Control vs. I respectively if not
mentioned otherwise, p < 0.001) and birth weight (1090 vs.
770, p < 0.001) were lower in the I group than in the control
group. In our study, a total of 29 infants (30%) were SGA
(14 in the control group and 15 in the I group). There was
no significant difference in birth head circumference (z-
score) between groups (− 0.49 vs. -0.61, p = 0.255). The 1-
min and 5-min Apgar scores were significantly lower in the
I group and neonatal morbidities including RDS, BPD,
PDA operation, and ROP (≥stage III) were significantly
more frequent in the I group. (Table 1). Therefore, GA and
morbidities were adjusted for the group comparison.
Short-term neurological and CA of 18months
neurodevelopmental outcome
Head circumference (HC) z-scores at 36 weeks of PMA
were significantly smaller in the I group. (− 1.45 vs.
-2.12; Control vs. I respectively if not mentioned other-
wise, p < 0.049). HCs z-scores at a CA of 18 months were
also significantly smaller in the I group (0.32 vs. -0.88,
p < 0.005).
Infants in the I group had significantly more WMI on
the MRI at discharge than those in the control group (2
vs. 26.7%, p = 0.036). At 35 weeks of PMA, significantly
lower maturation scores of aEEG were revealed in the I
group (9.5 vs. 8, p = 0.017) (Table 2). When comparing
Bayley-III scores at a CA of 18 months to those of the
control group adjusted for GA, the I group had signifi-
cantly lower scores in all domains except the social-
emotional. However, when further adjusted for neonatal
morbidities, only the motor domain showed significant
difference (100 vs. 91, p = 0.029). There was no signifi-
cant difference in the incidence of cerebral palsy be-
tween the control and the I group (Table 2).
The patients with culture-proven sepsis or stage II or
higher NEC had no significantly different neurologic
outcomes when compared with patients with the rest of
the I group. In addition, when we compared levels of
cytokine, brain injury markers, and CRP and the I/T ra-
tio, there was no significant difference except for higher
CRP levels in infants with culture-proven sepsis or stage
II or higher NEC.
Association of aEEG with poor neurodevelopment during
systemic inflammation
At the onset of systemic inflammation, there was a sig-
nificant correlation between I/T ratio and aEEG at the
day of symptom onset (D0). When the I/T ratio was
high, D0 aEEG showed a lower maturation score
Fig. 1 Flow diagram of the cohort study. aEEG, amplitude-integrated electroencephalography; PMA, post menstrual age; CA, corrected age
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(Pearson correlation coefficient with p-value, F − 0.496,
p = 0.026) and more frequent seizure spikes (F − 0.584,
p = 0.007). CSF IL-1 beta also showed a significant asso-
ciation with the maturation score (F − 0.662, p = 0.019),
seizure (F − 0.858, p = 0.001) and voltage-based classifica-
tion (F 0.608, p = 0.036) in D0 aEEG. Among brain in-
jury markers, MBP showed a significant association with
seizure (F − 0.566, p = 0.044) (Table 3).
Seizure spike on D0 aEEG had a significant correlation
with motor (F 0.581, p = 0.007) and social-emotional (F
0.544, p = 0.013) domains of Bayley-III at a CA of 18
months (Table 4).
Biomarkers during systemic inflammation associated with
poor neurodevelopment
In the correlation analysis, the higher the D0 I/T ratio,
the more WMI in brain MRI at discharge (F 0.483, p =
0.031). Several CSF biomarkers showed a significant
negative correlation with HC at 36 weeks of PMA: IL-8
(F − 0.742, p = 0.014), TNF-alpha (F − 0.771, p = 0.009),
S100B (F − 0.792, p = 0.006), and Enolase 2 (F − 0.729,
p = 0.017). Among plasma samples, only Enolase-2 pre-
sented a negative correlation with HC at 36 weeks. There
was no significant correlation between biomarkers and
aEEG parameters at 35 weeks PMA (Table 3).
I/T ratio was negatively correlated with the motor (F
− 0.530, p = 0.016) and social-emotional (F − 0.467, p =
0.038) domains in Bayley-III at a CA of 18 months. D0
CRP was negatively correlated with the language (F −
0.330, p = 0.033) and motor (F − 0.330, p = 0.033) do-
mains. Among the biomarkers, plasma TNF-alpha par-
ticularly showed a significant correlation with most
domains of Bayley-III: the cognitive (F − 0.662, p =
0.037), the motor (F − 0.749, p = 0.013), and the adaptive
behavior (F − 0.783, p = 0.007). In addition, CSF IL-1
beta showed a significant negative correlation with the
Table 1 Perinatal Characteristics, Neonatal Morbidities and Laboratory Result
Control (n = 49) I (n = 45) P-value
Gestational age (week) 29+ 2 (24+ 1, 34+ 2) 26+ 6 (24+ 0, 33+ 1) < 0.001*
Birth weight (g) 1090 (540, 1340) 770 (420, 1400) < 0.001*
Birth HC (z-score) −0.49 (− 3.28, 2.55) − 0.61 (−4.26, 0.98) 0.255
Male 20 (40.8) 28 (62.2) 0.100
Multiple birth 21 (42.9) 20 (44.4) 0.877
Apgar score
At 1 min 5 (1, 8) 3 (0, 8) 0.028*
At 5 min 7 (1, 9) 7 (0, 9) 0.004*
Cesarean section 33 (67.3) 28 (62.2) 0.440
PROM 10 (20.4) 7 (15.6) 0.541
HCA 19 (38.8) 21 (46.7) 0.440
Preeclampsia 2 (4.1) 3 (6.7) 0.577
Antenatal steroid 42 (85.7) 41 (91.1) 0.294
SGA 14 (28.6) 15 (33.3) 0.618
RDS 26 (53.1) 35 (77.8) 0.012*
Moderate to severe BPD 11 (22.4) 30 (66.7) < 0.001*
PDA operation 2 (4.1) 14 (31.1) < 0.001*
ROP ≥ stage III 2 (4.1) 15 (33.3) < 0.001*
IVH, grade III 0 (0.0) 2 (4.4) 0.136
Culture Proven Sepsis 0 (0.0) 11 (24.4) < 0.001*
NEC ≥ stage II 0 (0.0) 2 (4.44) < 0.001*
The number of Inflammatory episode 1 (1, 6) –
Postnatal days of Inflammatory episode 17 (0, 85) –
WBC (×103/μl) – 11.44 (1.00, 39.00) –
I/T ratio – 0.00 (0.00, 0.89) –
Platelet (×103/μl) – 157 (30, 811) –
CRP (mg/dL) – 1.96 (0.01, 18.21) –
Values are presented as median (min, max), or number (%)
HC head circumference; PROM premature rupture of membranes; HCA histologic chorioamnionitis; SGA small for gestational age; RDS respiratory distress
syndrome; BPD bronchopulmonary dysplasia; PDA patent ductus arteriosus; ROP retinopathy of prematurity; IVH intraventricular hemorrhage; I/T ratio immature to
total neutrophil ratio; CRP C-reactive protein
* p < 0.05
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social-emotional domain (F − 0.764, p = 0.016) (Table 5).
In correlation analysis, IL-6 was not significantly associ-
ated with neurological outcomes.
Head circumference and neurodevelopment at a CA of
18months
After adjusting for the GA and PMA of the inflamma-
tion episode, the HC at 36 weeks of PMA and at a CA of
18 months were correlated (F 0.740, p < 0.001). In
addition, there was a significant positive correlation be-
tween the HC at 36 weeks of PMA and the Bayley scores
(motor, F 0.345, p = 0.032; adaptive behavior, F 0.368,
p = 0.012) (Table 4).
Discussion
Preterm infants who experienced systemic inflammation
in the NICU had smaller head sizes and abnormal func-
tional brain maturation at near-term age, more WMI at
discharge, and had poor neurodevelopment at a CA of
18 months. In addition, the analyses to find associated
factors for poor neurodevelopment revealed that ele-
vated levels of I/T ratio, CRP, and plasma TNF-alpha
and the presence of seizure spikes on aEEG at the initial
phase of inflammatory episodes were correlated with
neurodevelopmental outcomes. Our study is the first to
comprehensively evaluate head growth, blood markers,
aEEG, brain MRI, and neurodevelopment at a later stage
in premature infants who experienced systemic
inflammation.
The HC at 36 weeks of PMA was smaller in the I
group compared to that in the control group. The group
differences in HC were maintained at a CA 18months
after adjusting for GA. The HC at 36 weeks of PMA also
correlated with Bayley scores at a CA of 18 months.
Therefore, smaller head size at 36 weeks of PMA shown
in the I group could be an indicator of poor neurodeve-
lopment at a later stage.
Infants in the I group had significantly more WMI on
the conventional MRI at discharge than those in the
control group. A recent study using diffusion MRI re-
ported differences in the white matter microstructure of
the corpus callosum of 6-year-old preterm children in
relation to the presence or absence of severe inflamma-
tory conditions in the neonatal period [23]. The authors
concluded neonatal inflammation is one medical factor
that may contribute to variation in long-term neurobio-
logical and neuropsychological outcomes in preterm
infants.
Compared to the control group after adjusting for GA,
the I group had significantly lower cognitive, language,
motor, and adaptive behavior scores. However, when the
morbidities were adjusted as well, only the motor do-
main remained significant. Previous studies suggested
that preterm infants with postnatal sepsis or NEC are
more likely to have adverse neurodevelopment [4, 5, 7,
24, 25]. In our study, infants with systemic inflammation
without proven sepsis or NEC also had delayed matur-
ation on aEEG, more WMI, and adverse CA of 18
Table 2 Short-term Neurological and CA of 18 months Neurodevelopmental Outcome
Control (n = 49) I (n = 45) P-value† P-value§
HC at PMA 36 weeks (z-score) −1.45 (−3.92, 0.51) −2.12 (−5.28, 0.17) < 0.001* 0.049*
aEEG at PMA 35weeks
Maturation score 9.50 (4, 13) 8 (4, 12) 0.002* 0.017*
WMI on MRI at discharge 0.008* 0.036*
None 48 (98) 33 (73.3)
Mild 1 (2) 8 (17.8)
Moderate to severe 0 (0) 4 (8.9)
HC at a CA of 18months (z-score) 0.32 (−2.42, 2.36) − 0.88 (−3.91, 2.13) < 0.001* 0.005*
Bayley-III and Cerebral palsy at a CA of 18months
Cognitive 95 (85, 125) 90 (55, 120) 0.006* 0.076
Language 97 (74, 121) 89 (50, 121) 0.015* 0.108
Motor 100 (82, 118) 91 (46, 110) 0.002* 0.029*
Social Emotional 95 (80, 110) 90 (55, 115) 0.066 0.311
Adaptive Behaviour 92 (61, 115) 84 (48, 111) 0.005* 0.055
Cerebral palsy 2 (4.0) 6 (13.3) 0.080 0.240
Values are presented as average (min, max), or number (%)
†P-values are adjusted for gestational age
§P-values are adjusted for gestational age, Apgar score, RDS, BPD, PDA operation, ROP (≥stage III), and IVH (≥Grade III)
HC head circumference; aEEG amplitude-integrated EEG; PMA Postmenstrual age; WMI White matter injury; MRI magnetic resonance imaging; CA corrected age,
Bayley-III Bayley Scales of Infant and Toddler Development III
* p < 0.05
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months neurodevelopmental outcomes indistinguishable
from infants with proven sepsis or NEC; this has been
inconsistently shown in previous studies. Some studies
reported that clinical infection without proven sepsis
was also associated with poor neurodevelopment or
brain white matter abnormalities [4, 26], but in another
study, the major impact on neurodevelopmental outcomes
was confined to preterm infants with proven sepsis [7].
We attempted to identify biomarkers associated with a
high risk for neurodevelopmental impairment among
infants with systemic inflammation. First, we analyzed
whether the aEEG was associated with poor neurodeve-
lopmental outcomes. The seizure spike on D0 aEEG had
significant relationship with the motor and social-
emotional domains. The increase in I/T ratio and CSF
IL-1 beta, which are the indices of systemic and central
nervous system inflammation, respectively, was signifi-
cantly related to an increased seizure spike and low mat-
uration of D0 aEEG. This finding implies that abnormal
aEEG findings at symptom onset might be
Table 4 Correlation between Neurologic Markers during Admission and Neurodevelopment (CA of 18 months) in the Inflammation
Group























Language −0.127 0.171 −0.102 0.246 0.408*
(0.021)
−0.293 − 0.271 0.210
Motor 0.141 0.581*
(0.007)
−0.269 0.161 0.227 0.030 −0.431*
(0.006)
0.345* (0.032)












HC at a CA of 18
months
− 0.092 0.031 − 0.002 0.177 – − 0.174 − 0.167 0.740*
(< 0.001)
Day 0: the day of inflammatory symptom onset
The values are Pearson correlation coefficient. If the p-value is less than 0.05, with (p-value)
All values are adjusted for gestational age and postmenstrual age of inflammatory event
aSeizure (1: yes, 2: no), bVoltage based classification (1: normal, 2: moderate abnormal, 3: severe abnormal), ¶Brain WMI (1: normal, 2: mild, 3: moderate to severe)
aEEG amplitude-integrated EEG; PMA Postmenstrual age; WMI White matter injury; HC Head circumference
* p < 0.05
Table 5 Correlation between Biomarkers (Day 0) and Neurodevelopment (CA of 18 months) in the Inflammation Group
I/T ratio let CRP IL-1 beta IL-8 TNF alpha S100B Enolase2 MBP
C P C P C P C P C P C P
HC: CA of 18
months (z-
score)
−0.018 0.200 − 0.032 − 0.110 − 0.388 −0.343 0.403 −0.562 − 0.792*
(0.006)
−0.429 − 0.216 −0.326 − 0.763*
(0.010)
−0.172 − 0.309
Bayley score: 18 months of CA
Cognitive −0.307 0.062 −0.294 −0.604 − 0.086 0.246 − 0.255 0.141 − 0.662*
(0.037)
0.127 0.134 0.209 −0.090 −0.287 − 0.352
Language −0.032 0.102 −0.204
(0.050)
− 0.270 −0.133 0.208 −0.270 − 0.117 −0.617*
(0.058)







− 0.005 0.067 − 0.221 −0.052 − 0.749*
(0.013)





0.019 −0.222 − 0.764*
(0.016)
0.383 0.420 −0.098 0.395 −0.452 0.554 −0.191 0.533 −0.252 − 0.152 −0.632
(0.050)
Adaptive −0.325 0.119 −0.300 −0.405 − 0.186 0.202 − 0.083 −0.161 − 0.783*
(0.007)
0.140 − 0.043 0.255 − 0.295 −0.074 − 0.504
Day 0: the day of inflammatory symptom onset
The values are Pearson correlation coefficient. If the p-value is less than 0.05, with (p-value). All values are adjusted for gestational age and
postmenstrual age of inflammatory event
C Cerebrospinal fluid; P plasma; MBP Myelin Basic Protein; TNF alpha Tumor Necrosis Factor-alpha; HC head circumference; CA corrected age
* p < 0.05
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mechanistically linked to the inflammatory status in in-
fants. Septic adult patients without central nervous sys-
tem infection develop diffuse cerebral dysfunction and
show characteristic EEG findings, known as sepsis-
associated encephalopathy [27]. Preterm infants also
show acute electroencephalographic changes such as
burst suppression during sepsis [15].
Second, blood markers during inflammatory episodes
were analyzed. It is well known that an increased I/T ra-
tio and CRP and thrombocytopenia suggest infection
[28, 29]. D0 CRP was negatively correlated with the lan-
guage and motor domains, and the D0 I/T ratio was
negatively correlated with the motor and social-
emotional domains. Several studies have shown that
brain injury is associated with high inflammatory cyto-
kine levels [30–32]. We analyzed inflammatory cytokines
and brain injury markers from D0 plasma and CSF. CSF
IL-8, TNF-alpha, S100B, and Enolase 2 showed negative
correlations with HC at 36 weeks of PMA; however, they
were not correlated with HC at a CA of 18 months or
Bayley scales. In a previous study, concentrations of
inflammation-related proteins including IL-6, TNF-R2,
IL-8, MCP-1, and ICAM-1 in plasma were associated
with the risk of microcephaly at a CA of 2 years [33].
Unlike other plasma markers, plasma TNF-alpha was
correlated with scores of many domains in Bayley scales
and HC at a CA of 18 months. On the other hand, CSF
TNF-alpha was not associated with neurodevelopment
and only correlated with HC at 36 weeks of PMA as with
other CSF cytokines and brain injury markers. This find-
ing might imply the critical role of plasma TNF-alpha in
the mechanism of inflammation-associated brain injury
in preterm infants. In the Extremely Low Gestational
Age Newborn (ELGAN) study, elevated levels of TNF-
alpha in blood collected on postnatal day 14 are associ-
ated with impaired mental and motor development at 2
years of age [34]. From the same cohort, preterm infants
who had sustained elevations of inflammation-related
proteins including CRP, TNF-alpha, and IL-8 in the first
postnatal month are reported to be more likely to have
cognitive impairment at 10 years of age [35]. While the
ELGAN study collected cytokine samples independent
of inflammatory events, our study analyzed the cytokines
from samples obtained at the time of systemic inflamma-
tion. We think our approach has the potential to set an
appropriate timing for collecting samples when we in-
vestigate the effect of systemic inflammation on brain in-
jury and subsequent neurodevelopment because blood-
brain barrier disruption is known to be a late or terminal
event seen in large-scale activations of the immune
system, such as sepsis [9].
From the above results, aEEG findings and blood bio-
markers during inflammatory episodes were associated
with poor neurodevelopment. Interestingly, the
neurodevelopmental outcomes were more closely associ-
ated with usual laboratory markers of I/T ratio or CRP
rather than most of the inflammatory cytokines or brain
injury markers investigated in this study. Notably, this is
an observational cohort study; therefore, causation of
study findings cannot be concluded, although there were
some significant correlations between aEEG, CRP, and
plasma TNF-alpha during inflammation and late-stage
Bayley scores.
Our study has several strengths. We attempted to cap-
ture the point of significant systemic inflammation and
conducted a comprehensive evaluation encompassing
growth, body fluid biomarkers, neurophysiologic study,
brain imaging, and CA of 18months neurodevelopmen-
tal outcomes. We performed Bayley-III, which provides
not only granular evaluation of cognitive, language, and
motor development, but also social-emotional and adap-
tive behavior. This has enabled us to examine more di-
verse aspects of development in study infants.
Limitations of this study are the sample size is modest
from a single center, and aEEG and cytokine analysis
during inflammation were partly performed in the I
group. The D0 may not be the first day of an inflamma-
tory episode for infants exposed to chorioamnionitis
because sepsis workup was performed only when symp-
toms of systemic infection were present.
Conclusion
Our prospective cohort study showed that systemic in-
flammation induced by clinical infection and NEC is as-
sociated with poor neurodevelopment in preterm
infants. The seizure spike on aEEG and elevated I/T ra-
tio, CRP, and plasma TNF-alpha during inflammatory
episodes are associated with poor neurodevelopmental
outcomes among preterm infants who were exposed to
systemic inflammation. These results may help estimate
the neurodevelopmental risk of individual patients who
have inflammatory illness and narrow down the target
population of neuroprotection in the future.
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